Total Liabilities Summary of Adimmune Corporation

Adimmune Corporation's latest annual total liabilities in 2023 was 3.7 Billion TWD , up 42.37% from previous year.
Adimmune Corporation's latest quarterly total liabilities in 2024 Q1 was 3.75 Billion TWD , up 1.41% from previous quarter.
Adimmune Corporation reported annual total liabilities of 2.6 Billion TWD in 2022, up 65.05% from previous year.
Adimmune Corporation reported annual total liabilities of 1.57 Billion TWD in 2021, down -14.48% from previous year.
Adimmune Corporation reported quarterly total liabilities of 3.75 Billion TWD for 2024 Q1, up 1.41% from previous quarter.
Adimmune Corporation reported quarterly total liabilities of 3.16 Billion TWD for 2023 Q2, up 11.77% from previous quarter.

Annual Total Liabilities Chart of Adimmune Corporation (2023 - 2009)

Historical Annual Total Liabilities of Adimmune Corporation (2023 - 2009)

Year	Total Liabilities	Total Liabilities Growth
2023	3.7 Billion TWD	42.37%
2022	2.6 Billion TWD	65.05%
2021	1.57 Billion TWD	-14.48%
2020	1.84 Billion TWD	-32.79%
2019	2.74 Billion TWD	-28.19%
2018	3.82 Billion TWD	12.53%
2017	3.39 Billion TWD	-7.95%
2016	3.68 Billion TWD	110.9%
2015	1.74 Billion TWD	25.9%
2014	1.38 Billion TWD	-38.22%
2013	2.24 Billion TWD	-0.05%
2012	2.25 Billion TWD	11.97%
2011	2 Billion TWD	48.38%
2010	1.35 Billion TWD	-30.24%
2009	1.94 Billion TWD	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q2	3.32 Billion TWD	-11.45%
2024 Q1	3.75 Billion TWD	1.41%
2023 Q2	3.16 Billion TWD	11.77%
2023 Q4	3.7 Billion TWD	21.83%
2023 Q1	2.83 Billion TWD	8.71%
2023 FY	3.7 Billion TWD	42.37%
2023 Q3	3.04 Billion TWD	-3.82%
2022 Q3	2.64 Billion TWD	-1.66%
2022 FY	2.6 Billion TWD	65.05%
2022 Q1	1.85 Billion TWD	17.55%
2022 Q2	2.68 Billion TWD	44.84%
2022 Q4	2.6 Billion TWD	-1.42%
2021 FY	1.57 Billion TWD	-14.48%
2021 Q3	1.94 Billion TWD	-2.64%
2021 Q4	1.57 Billion TWD	-18.83%
2021 Q2	1.99 Billion TWD	1.91%
2021 Q1	1.95 Billion TWD	6.19%
2020 Q2	1.74 Billion TWD	-11.78%
2020 Q3	1.45 Billion TWD	-16.95%
2020 Q4	1.84 Billion TWD	27.0%
2020 FY	1.84 Billion TWD	-32.79%
2020 Q1	1.98 Billion TWD	-27.77%
2019 Q1	3.71 Billion TWD	-2.86%
2019 Q2	3.43 Billion TWD	-7.44%
2019 Q3	2.89 Billion TWD	-15.67%
2019 FY	2.74 Billion TWD	-28.19%
2019 Q4	2.74 Billion TWD	-5.29%
2018 Q4	3.82 Billion TWD	6.49%
2018 FY	3.82 Billion TWD	12.53%
2018 Q1	3.5 Billion TWD	3.12%
2018 Q2	3.61 Billion TWD	3.2%
2018 Q3	3.58 Billion TWD	-0.7%
2017 Q2	3.4 Billion TWD	-5.08%
2017 Q1	3.59 Billion TWD	-2.65%
2017 FY	3.39 Billion TWD	-7.95%
2017 Q4	3.39 Billion TWD	3.21%
2017 Q3	3.29 Billion TWD	-3.48%
2016 FY	3.68 Billion TWD	110.9%
2016 Q4	3.68 Billion TWD	58.48%
2016 Q3	2.32 Billion TWD	10.86%
2016 Q2	2.1 Billion TWD	21.01%
2016 Q1	1.73 Billion TWD	-0.8%
2015 Q2	1.51 Billion TWD	12.42%
2015 Q3	1.58 Billion TWD	4.43%
2015 FY	1.74 Billion TWD	25.9%
2015 Q4	1.74 Billion TWD	10.7%
2015 Q1	1.34 Billion TWD	-3.13%
2014 Q1	2.39 Billion TWD	6.44%
2014 FY	1.38 Billion TWD	-38.22%
2014 Q4	1.38 Billion TWD	-29.8%
2014 Q2	2.48 Billion TWD	3.85%
2014 Q3	1.97 Billion TWD	-20.38%
2013 Q2	2.35 Billion TWD	2.03%
2013 Q4	2.24 Billion TWD	-2.15%
2013 FY	2.24 Billion TWD	-0.05%
2013 Q1	2.3 Billion TWD	2.6%
2013 Q3	2.29 Billion TWD	-2.43%
2012 Q4	2.25 Billion TWD	0.34%
2012 Q3	2.24 Billion TWD	3.62%
2012 Q1	2.17 Billion TWD	8.12%
2012 FY	2.25 Billion TWD	11.97%
2012 Q2	2.16 Billion TWD	-0.39%
2011 Q4	2 Billion TWD	8.96%
2011 Q2	1.47 Billion TWD	0.0%
2011 Q3	1.84 Billion TWD	25.39%
2011 FY	2 Billion TWD	48.38%
2010 FY	1.35 Billion TWD	-30.24%
2010 Q4	1.35 Billion TWD	0.0%
2009 FY	1.94 Billion TWD	0.0%

Peer Total Liabilities Comparison of Adimmune Corporation

Name	Total Liabilities	Total Liabilities Difference
Apex Biotechnology Corp.	500.07 Million TWD	-641.271%
Sinphar Pharmaceutical Co.,Ltd.	2.85 Billion TWD	-29.919%
Panion & Bf Biotech Inc.	1.32 Billion TWD	-179.954%
Chunghwa Chemical Synthesis & Biotech Co., Ltd.	1.82 Billion TWD	-103.516%
GenMont Biotech Incorporation	204.05 Million TWD	-1716.569%
Abnova (Taiwan) Corporation	69.42 Million TWD	-5239.468%
Tanvex BioPharma, Inc.	1.94 Billion TWD	-90.85%
Polaris Group	1.46 Billion TWD	-153.066%
Energenesis Biomedical CO.,LTD.	24.58 Million TWD	-14976.553%
UnicoCell Biomed Co., Ltd.	89.48 Million TWD	-4042.358%
PELL Bio-Med Technology Co. Ltd.	236.76 Million TWD	-1465.633%

Global Stocks Search

Adimmune Corporation (4142.TW)

Total Liabilities Summary of Adimmune Corporation

Annual Total Liabilities Chart of Adimmune Corporation (2023 - 2009)

Historical Annual Total Liabilities of Adimmune Corporation (2023 - 2009)

Peer Total Liabilities Comparison of Adimmune Corporation